Paper Details

  1. Home
  2. Paper Details

Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.

Author: NelsonH S, WeberR W

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Pirbuterol is a beta 2 adrenergic agonist that is effective in treating chronic obstructive pulmonary disease. It is comparable to albuterol in terms of duration of action, potency, and side effects.
Paper Details　
Original Abstract of the Article :
Pirbuterol hydrochloride is a beta 2 adrenergic agonist with a structure similar to that of albuterol, except for the substitution of a pyridine ring for the benzene ring. It is comparable in duration of action to albuterol when given by inhalation, but it is threefold less potent by weight. In man,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/j.1875-9114.1984.tb03301.x

データ提供：米国国立医学図書館（NLM）

Pirbuterol Hydrochloride: A New Hope for Respiratory and Cardiac Conditions

The quest for effective treatments for respiratory and cardiac conditions is a continuous journey. This research investigates pirbuterol hydrochloride, a beta 2 adrenergic agonist, as a potential therapeutic agent for both reversible obstructive pulmonary disease and congestive heart failure. The authors compare pirbuterol to other beta 2 agonists, such as albuterol and terbutaline, and discuss its efficacy in both acute and long-term treatment. This study highlights the potential of pirbuterol as a valuable tool for managing these conditions, offering a new oasis of hope in the desert of chronic illness.

A New Approach to Managing Respiratory and Cardiac Conditions

This research highlights the potential benefits of pirbuterol hydrochloride for both respiratory and cardiac conditions. The authors' findings suggest that pirbuterol offers a viable therapeutic option for managing these conditions, potentially offering relief to individuals struggling with these ailments.

The Oasis of Pirbuterol Hydrochloride

This research underscores the importance of seeking out new and effective treatment options for respiratory and cardiac conditions. The study emphasizes the potential of pirbuterol hydrochloride as a valuable tool for managing these conditions, offering hope for a brighter future for those seeking relief from these ailments.

Dr.Camel's Conclusion

This research offers a ray of hope in the ongoing search for effective treatments for respiratory and cardiac conditions. The potential of pirbuterol hydrochloride as a valuable therapeutic agent for these conditions adds to the growing arsenal of tools available to healthcare professionals. This research serves as a reminder that the desert of chronic illness can be navigated with perseverance and the pursuit of new and innovative solutions.

Date :
  1. Date Completed 1984-04-16
  2. Date Revised 2019-09-13
Further Info :

Pubmed ID

6142449

DOI: Digital Object Identifier

10.1002/j.1875-9114.1984.tb03301.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.